Termination in Full Clause Samples

Termination in Full. Concurrently with any reduction of the Total Commitment to zero, the Company shall pay all accrued interest, fees and other amounts payable hereunder and Cash Collateralize all outstanding Letters of Credit.

Termination in Full. Notwithstanding the foregoing provisions of this Section 2.07, the Borrower shall be permitted to make a sale of Loans not subject to the restrictions set forth above provided the Borrower repays all Obligations in full, pays any related Optional Prepayment Penalty payable in respect of such termination and repayment and terminates this Agreement in accordance with Section 2.18(b).

Termination in Full. In the event of termination of this Agreement in its entirety for any reason: (a) except as set forth in this Section 11.6.1 or Section 11.8, all rights and licenses granted herein shall terminate in full with respect to a termination of this Agreement; (b) except as set forth in this Section 11.6.1 or Section 11.8, all obligations of Editas and Juno hereunder shall terminate; (c) each Party shall return or destroy all Confidential Information of the other Party as required by ARTICLE 8 (other than joint Confidential Information), except as reasonably necessary to exercise any surviving rights and except for one copy of which may be retained for archival purposes (which shall remain subject to the confidentiality and non-use provisions of ARTICLE 8); and (d) notwithstanding the foregoing provisions of this Section 11.6, the licenses granted to Juno hereunder shall survive for twelve (12) months following the effective date of termination in order for Juno (and its Affiliates, Sublicensees and Distributors), at Juno’s discretion, during the twelve (12)-month period immediately following the effective date of termination, to (i) finish or otherwise wind-down any ongoing Clinical Trials with respect to any Licensed Products hereunder; and (ii) finish and sell any work-in-progress and any Licensed Products remaining in inventory; provided that Juno shall pay royalties on Annual Product Net Sales of such Licensed Products sold by Juno during such period, to the extent during the applicable Royalty Term, as and to the extent Juno would otherwise be required to pay such royalties as set forth in Section 6.2; provided, however, that Juno shall have no obligation to undertake such activities, in each case of (i) and (ii), as and to the extent determined by Juno.

Termination in Full. (a) This Agreement shall terminate in full as provided in Section 6.1 hereof. (b) At any time, upon ninety (90) days' prior notice to Xoma, Pfizer shall have the right, without cause at Pfizer's sole discretion, to terminate in full this Agreement, whereupon this Agreement together with the License Agreement and Supply Agreement shall terminate ninety (90) days after the date of such notice. (c) If either Pfizer or Xoma materially breaches or defaults in the performance or observance of any of the provisions of this Agreement and such breach or default is not cured within ninety (90) days or, in the case of failure to pay any amounts due hereunder, sixty (60) days after the giving of notice by the other party specifying such breach or default, the other party shall have the right to terminate this Agreement in full upon a further thirty (30) days' notice. (d) Upon any termination under Section 10.3(b) hereof or Section 9.02 of the License Agreement, Pfizer shall be responsible for all Development Costs incurred by Xoma with respect to Subject Products during the ninety (90) day period following the date of notice of termination as well as reasonable termination costs incurred by Xoma thereafter (including reasonable severance payments and reasonable buy-outs of preexisting contracts reasonably entered into); provided, however, Xoma shall use best efforts to mitigate and control such termination costs. (e) In the event of termination in full of this Agreement under Sections 6.1 or 10.3 hereof, subject to Section 9.05 of the License Agreement Pfizer will have no rights and Xoma will have no further obligations under this Agreement, the License Agreement, or the Supply Agreement (except for obligations under Section 8.2 and 9.1 hereof or under the Security Agreement), and Pfizer will immediately return to Xoma all Technical Information.

Termination in Full. Upon and in consideration for the payment of the Unwind Payment on the Settlement Date pursuant to Section 4 below, (1) the Base Convertible Bond Hedge Confirmation and all remaining Options thereunder, representing [_____] Options (the “Terminated Base Options”), shall be shall be terminated in full; (2) the Additional Convertible Bond Hedge Confirmation and all Options thereunder, representing [_____] Options (the “Terminated Additional Options” and together with the Terminated Base Options, the “Terminated Options”) shall be terminated in full; (3) all of the respective rights and obligations of the parties under the Base Convertible Bond Hedge Confirmation and all of the respective rights and obligations of the parties under the Additional Convertible Bond Hedge Confirmation with respect to the Terminated Base Options shall be cancelled and terminated; and (4) each party shall be released and discharged by the other party, and agrees not to make any claim with respect to any obligations of the other party, in connection with the Terminated Options; provided that the representations and warranties contained or incorporated by reference in the Convertible Bond Hedge Confirmations, and any indemnification or contribution obligations contained therein arising as a result of events occurring on or prior to the Settlement Date, shall survive such terminations.